Wellysis ECG Patch Hits US, Indian Markets

Digital healthcare innovator Wellysis is securing strategic partnerships.

Image credits: Wellysis

Digital healthcare innovator Wellysis is making waves in the global market with its revolutionary electro cardiogram (ECG) monitoring solution, 'S-Patch,' securing strategic partnerships and distribution deals to propel its entry into the lucrative US and Indian markets.

Wellysis inked a significant supply agreement with a leading US provider of ECG services in November 2023, paving the way for S-Patch distribution across three important states: Texas, Arizona, and Louisiana, with the rollout starting in Texas. The initial deployment of 1,000 devices in late January marks the beginning of a two-year supply commitment, solidifying Wellysis's presence in the world's largest ECG market,which holds a share of over 60% of the total market.

To fuel its US ambitions, Wellysis strategically established a subsidiary in Houston, Texas, through the Johnson & Johnson Innovation Laboratories (JLABS) and continues to forge partnerships for further expansion beyond the central region.

Additionally, Wellysis partnered with Dozee, a prominent bed monitoring solutions provider based in India, in October 2023. Following a successful product launch event in New Delhi, Wellysis is poised to integrate and supply S-Patch devices to 50,000 of Dozee's hospital beds starting in January.

Related Gel-FreeECG Sensor Monitors Heart Health

"The US and India offer unparalleled opportunities for Wellysis," remarked Young Juhn, CEO of Wellysis."With these strategic partnerships, we're confident in S-Patch's success.Our focus is on showcasing S-Patch's versatility through diverse use cases, from remote patient monitoring to hospital bed integration."

About Wellysis

Wellysis is a digital healthcare company dedicated to revolutionizing patient care through innovative ECG monitoring solutions. Its flagship product, S-Patch, is a user-friendly, wearable ECG monitor that provides real-time data and advanced analysis, empowering clinicians and patients alike.

Sam Draper
January 30, 2024

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

How to Track Your Blood Oxygen Saturation Using Wearables Like Smartwatches

Many people with COVID-19 have low levels of oxygen in their blood, even when they feel well. Low...

FDA Nod For Apple Watch-Based App Parkinson's Disease

The FDA has given clearance H2o Therapeutics for its mobile app for monitoring Parkinson’s Disease.

FDA Issues Recall for Eversense Continuous Glucose Monitoring System

The US Food and Drug Administration (FDA) has issued a recall for Senseonics’ Eversense...

Taiwan-Based Healthcare Startup iWEECARE Scores US$1M in Pre-Series A round

iWEECARE, bagged US$1 million in a pre-series A round led by Singapore’s Verge HealthTech Fund.
Discover more